clinical trial · NCT07503444
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
UCB BIOSCIENCES, Inc.·phase3·recruiting·n = 200
Rett Syndromefenfluramine hydrochloridePlacebo
brief summary
The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).
started
Jul 14, 2026
primary completion
Feb 6, 2029
completion
Aug 29, 2031
last updated
Aug 17, 2026
official title
A Phase 3 Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study With Open-Label Extension to Evaluate the Efficacy And Safety of Fenfluramine Hydrochloride in Study Participants With Rett Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol